|
STEP Ezine
Table of Contents, July 31, 2002 This issue we have a personal view on lipoatropy, a spotlight on a critical HIV/AIDS resource in our community and an answer to a question that seems to come up consistently on our TalkLine and in e-mails until next month.
Contents
AcknowledgementsPlease note that this is not a complete list of all HIV-related treatment information. STEP strives to provide the very latest in HIV treatment information, research and drug development information. The most current research directions and antiretroviral drug data are provided throughout the Ezine publications. You will find highlight reports as well as extensive follow-up reports from many of the AIDS research and science conferences on the Ezine. In addition, all STEP quarterly treatment journals are available on our Web site at www.thebody.com/step/steppage.html or by calling our Talkline at 1-877-597-STEP. STEP works hard to give unbiased treatment information to all interested parties. If you have comments, questions, suggestions or grievances, please contact robertog@lifelongaidsalliance.org or step@lifelongaidsalliance.org.Special thanks to the following for contributing written material or editing this publication:
We also appreciate the financial support for this program from: Disclaimer: STEP reviews a wide spectrum of HIV treatment options, but does not endorse any particular product, treatment, company, or individual. Participation in the preparation of the materials included in the STEP Ezine does not imply endorsement by any of the individuals who have contributed to the production.
This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine. |